Page last updated: 2024-11-06

prednisolone and Adenocarcinoma, Clear Cell

prednisolone has been researched along with Adenocarcinoma, Clear Cell in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Adenocarcinoma, Clear Cell: An adenocarcinoma characterized by the presence of varying combinations of clear and hobnail-shaped tumor cells. There are three predominant patterns described as tubulocystic, solid, and papillary. These tumors, usually located in the female reproductive organs, have been seen more frequently in young women since 1970 as a result of the association with intrauterine exposure to diethylstilbestrol. (From Holland et al., Cancer Medicine, 3d ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshinaga, A1
Hayashi, T1
Ohno, R1
Yoshida, S1
Ishii, N1
Terao, T1
Watanabe, T1
Yamada, T1

Reviews

1 review available for prednisolone and Adenocarcinoma, Clear Cell

ArticleYear
[A case of renal cell carcinoma associated with idiopathic thrombocytopenic purpura].
    Hinyokika kiyo. Acta urologica Japonica, 2005, Volume: 51, Issue:6

    Topics: Adenocarcinoma, Clear Cell; Adult; Anti-Inflammatory Agents; Carcinoma, Renal Cell; Female; Humans;

2005